Tweet
CBS News
<img alt="" height="1" width="1" />
FDA reviews 2 new drugs to reduce prostate cancer
BusinessWeek
Health regulators said Monday that two drugs from GlaxoSmithKline and Merck reduce the risk of prostate cancer in men, though scientists questioned the drugs' overall benefit, since the tumors they prevent are usually not ...
Prostate Cancer Prevented by Pill? Not So Fast, Experts SayCBS News
Glaxo's Avodart Faces FDA Questions on Prostate Cancer BenefitsBloomberg
FDA Documents Question Avodart's Prostate-Cancer Prevention PowerWall Street Journal (blog)
All About Top News -Reuters India
all 180 news articles »
More...